Royal Philips on June 21 announced that it has acquired PathXL, a Northern Ireland-based leader in digital pathology image analysis, workflow software and educational tools. PathXLâs image analysis and tissue pathology software will complement Philipsâ Digital Pathology Solutions offering, and help expand the businessâ leadership in this fast-growing field. Financial details of the transaction were not disclosed.
Pathology involves the examination of patient tissue samples and plays a crucial role in the diagnosis and treatment of a wide variety of diseases, including cancer. Philips is a pioneer and leader in the digitisation of pathology, a fast-growing area in healthcare as pathology labs are under pressure to improve throughput and efficiency, enhance quality and to deliver new diagnostic tests for precision medicine.
- The acquisition will accelerate the drive to support global medical institutions in their transition to digitised pathology workflows.
- The unique opportunity to amplify the combined technology leadership positions.
- Will enable integrated & intelligent solutions that fulfil many needs in computational pathology, education, workflow solutions and image analytics.
- Will enable high-quality quantitative analysis of digital whole slide images.
- Will enable pathologists to review and share large sets of clinical data using image analytics with the aim to help improve the quality of diagnosis and has the potential to enable new therapies and ultimately improve patient outcomes.
Understanding Philipsâ lntelliSite Pathology Solution
An automated digital pathology image creation, management and viewing system comprised of an ultra-fast pathology slide scanner, an image management system and dedicated software tools.
Overview -Â PathXL
PathXL, founded in 2004 and headquartered in Belfast, Northern Ireland, offers a range of digital pathology software applications to research and education segments of pathology and bio-pharma markets. The company has approximately 30 employees, offices in the United Kingdom (UK) and United States (US) and distributors across three continents.